Amel

$CABA early offering with Eli Lilly and others at 2.90, 51.75M shares, right before some data...

IN HONOR OF CALIFORNIA’S 175TH ANNIVERSARY, WE WILL BE ROLLING OUT A VERY SPECIAL DRIVER’S LICENSE FOR EVERY CALIFORNIAN THIS SUMMER! IT WILL FEATURE A HANDSOME, HIGH-QUALITY PHOTO OF ME, GAVIN C. NEWSOM. MANY PEOPLE ARE SAYING IT’S THE BEST LICENSE EVER MADE IN THE HISTORY OF THE WORLD. THIS IS ABOUT CELEBRATING OUR BEAUTIFUL STATE (IT IS NOT ABOUT ME, DESPITE THE VERY HANDSOME PHOTO!). ENJOY! — GOVERNOR GCN

@anthonystaj @houndcl @X Just create new account mayne

to those wondering..... @houndcl is definitely still suspended. @X simlpy does not care. but he's still alive, and continuing to sleuth!

A 35 pack at Costco is now $20, five years ago we were buying it for $12

Lulz..thats not gonna happen..

Thats insane..

Trumpski going in with a takbir 😂

I added some of the therapies from previous generations, to illustrate the progress that's been made here (in relapsed or refractory multiple myeloma after 1-3 lines of previous therapy) Pretty amazing!

@merricklackner 111M shares...

Why $CABA’s Ultra-Tight Locked Float (Only ~10–13 Million Shares Truly Available Today) Sets Up a Massive Surge Potential — Even Post-Warrant Exercise On the surface, Cabaletta Bio ($CABA) reports 96.27 million shares outstanding and a public float of 70.98 million shares. But the real story is the extreme lock-up: institutions own 79.25% (~76.3 million shares across 107 holders), and insiders hold another 1.57%. After subtracting the sticky core holders (T. Rowe Price, Bain Capital Life Sciences, Jennison Associates, and Adage Capital Partners alone control ~37+ million shares), the truly liquid, retail-available float collapses to just 10–13 million shares. That’s the effective supply that actually trades day-to-day. This setup is reinforced by 18.64 million shares short (21.8% of the float) and borrow availability stuck at ~1.8 million shares. Daily volume of 1.5–3 million shares means any real buying pressure (from data catalysts, short covering, or institutional adding) meets almost no selling from the long-term owners who aren’t going anywhere until the 2027 BLA or major readouts. Now layer in the warrants for full accuracy: There are exactly 53,090,190 common stock warrants outstanding from the 2025 offering (exercise price $2.50, no exercises reported in any filing through March 2026). If fully exercised, they add 53.09 million new registered shares directly to the public float. Post-execution math: ~149.36 million fully diluted shares outstanding and ~124.07 million fully diluted float. Even in that scenario, the original institutional blocks (~37+ million shares) remain locked, and many new warrant shares would likely flow to similar long-term buyers rather than immediate retail selling. The “dead money” dynamic doesn’t disappear — it just scales up while the truly liquid supply stays constrained relative to the opportunity. Biotech history shows exactly how this plays out: a name with strong science, locked float, and high short interest can rerate 5–10x+ when positive data hits (no-preconditioning durability expected as early as June 2026, Cellares GMP confirmation in H1 2026, full RESET readouts, and the lean myositis registrational path). At today’s ~$290–300 million market cap, a true “immune reset” across multiple autoimmune indications would turn the available supply shock into a violent move — whether pre- or post-warrant exercise. The big holders are locked for a reason. When the data confirms the cure-like potential, the float (current or fully diluted) simply won’t be able to absorb the demand. Do your own DD. This is not financial advice. Time will tell.

Sources: NBA votes in favor to explore Vegas, Seattle expansion - via @ESPN App espn.com/nba/story/_/id…

Gamblers trying to win a bet on Polymarket are vowing to kill me if I don’t rewrite an Iran missile story This is my account: timesofisrael.com/gamblers-tryin…

She did scare me 😂

@anthonystaj @houndcl @nikitabier What a fukin joke..take the suspenesion off

so our guy @houndcl of infamy has had his appeal denied. guilty of questioning research. #freehoundcl @nikitabier

NBA's ALL-TIME record for points in a single game: 1. Wilt Chamberlain: 100 points 2. Bam Adebayo, 83 points 3. Kobe Bryant, 81 points

Think I was the only one that wanted him to workout with the FDA...oh well

Here we go..

😲💀